Señales en vivo de TWST | Maximiza tus Ganancias con Getagraph.com

COMPRAR 249 min ago

@ $50.12

Emitido: 1 jul 2024 @ 11:23

Retorno: -2.46%

Señal anterior: jun 28 - 12:28

Señal anterior: Vender

Retorno: 3.45 %

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 15:33):
Our systems believe the stock currently is overvalued by -0.08% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	769 202
Volumen promedio	1.15M
Capitalización de mercado	2.85B
EPS	$-0.790 ( Q2 \| 2024-05-02 )
Próxima fecha de ganancias	( $-0.790 ) 2024-08-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.55 (Sector) 42.63 (Industry) 0
ATR14	$2.96 (6.06%)

ACRS 9.09%

AKU -17.87%

APDN 28.77%

BDSX 0.65%

BIOC 0.00%

BNGO -2.55%

BNR -2.86%

CDNA -1.22%

CEMI 0.22%

CHEK 4.04%

CNTG -2.01%

CSTL -3.31%

DMTK -11.32%

DRIO -2.69%

EXAS 0.05%

FLDM -7.02%

FLGT 2.47%

GENE -4.05%

GH -2.67%

GTH 0.12%

HTGM 0.00%

ICLR 0.80%

IDXX -2.28%

ILMN 0.96%

ISPC -1.74%

LAB -1.70%

LMDX 0.00%

MDXH -2.50%

ME -3.94%

MEDP -0.94%

MYGN -2.17%

MYNZ -17.71%

NDRA -3.19%

NEO 0.36%

NEOG -3.84%

NOTV -5.99%

NTRA -0.49%

OCDX 0.92%

OLK 0.10%

OPGN -0.39%

OPK -2.40%

PMD -2.89%

PRPO 0.89%

PSNL 1.29%

RDNT -0.87%

SERA 4.39%

SHC -3.24%

SQL 0.00%

STIM -2.78%

STRR -4.19%

STRRP -5.05%

SYNH 0.02%

TRIB 3.38%

TTOO 2.06%

TWST -0.80%

VIVO 0.00%

XGN 0.55%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Leproust Emily M.	Sell	1 732	Common Stock
2024-06-20	Green Paula	Sell	297	Common Stock
2024-06-20	Cho Dennis	Sell	234	Common Stock
2024-06-14	Cho Dennis	Sell	95	Common Stock
2024-06-06	Cho Dennis	Sell	276	Common Stock

INSIDER POWER
71.93
Last 100 transactions
Buy: 618 828 \| Sell: 89 680

Correlación (AI algo v.1.1b): Overvalued: -0.08% $48.88 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.94 (very strong negative)

Corto: 0.86 (strong)

Signal:(44) Same movement expected

Twist Bioscience Corp Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Twist Bioscience Corp Correlación - Moneda/Commodity

0.61
( weak )

0.55
( weak )

0.00
( neutral )

0.01
( neutral )

-0.83
( strong negative )

-0.21
( neutral )

Twist Bioscience Corp Finanzas

Annual	2023
Ingresos:	$245.11M
Beneficio Bruto:	$89.73M (36.61 %)
EPS:	$-3.60

FY	2023
Ingresos:	$245.11M
Beneficio Bruto:	$89.73M (36.61 %)
EPS:	$-3.60

FY	2022
Ingresos:	$203.57M
Beneficio Bruto:	$84.24M (41.38 %)
EPS:	$-4.04

FY	2021
Ingresos:	$132.33M
Beneficio Bruto:	$51.71M (39.08 %)
EPS:	$-3.15

Financial Reports:

No articles found.

Twist Bioscience Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Twist Bioscience Corp

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.